Rous Sarcoma Virus (RSV) and Cancer

Rous sarcoma virus (RSV) is a retrovirus discovered in 1911 that causes tumors in chickens. RSV integrates its RNA genome into host cell DNA and carries the viral Src oncogene, which produces a hyperactive mutated protein. When expressed in host cells, this protein drives abnormal cell growth and cancer progression, making RSV a cancer-causing infectious agent.

RSV contains two copies of plus-strand RNA with four main open reading frames: Gag, Pol, Env, and Src. The first three genes encode structural components and enzymes needed for viral replication. The Src gene is unique to RSV and encodes a protein tyrosine kinase that functions as an oncogene, distinguishing it from standard retroviral genomes.

Viral Src (v-Src) is a mutated homolog of the cellular proto-oncogene c-Src. While c-Src is essential for normal vertebrate cell growth, v-Src becomes hyperactive and oncogenic when expressed in host cells. RSV likely acquired the c-Src gene accidentally from a host cell in the past, and subsequent mutations transformed it into a cancer-causing oncogene.

Upon infection, RSV's RNA genome is reverse transcribed into proviral DNA. This proviral DNA then integrates into the host genome and is transcribed into RNA using host cell machinery. The viral RNA is masked to resemble cellular mRNA, allowing host ribosomes to translate it and produce all viral proteins, including the oncogenic Src protein.

The v-Src gene is irrelevant to RSV survival or replication. The virus carries it as an accidental acquisition from a past host cell that subsequently acquired mutations. While v-Src drives cancer in infected cells, it is not required for the virus to replicate or spread, making it a passenger oncogene rather than a core viral component.

F. Peyton Rous discovered RSV in 1911 as a filterable transmissible agent causing tumors in chickens, earning him the Nobel Prize in 1966. His experiments demonstrated that infectious agents could cause cancer, leading to the discovery of many cancer-causing viruses in animals and humans and establishing the viral etiology of certain cancers.

RSV's viral Src protein is a hyperactive protein tyrosine kinase that disrupts normal cellular signaling when expressed in host cells. This hyperactivity triggers abnormal cell proliferation and growth, ultimately leading to cancer progression. The mechanisms of retrovirus-induced cancers involve this oncogenic protein overriding normal cell growth controls.